ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Interview With Screening Expert Barnett Kramer, PLCO Investigator

March 20, 2009

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014